These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24973707)

  • 1. The selective PAC1 receptor agonist maxadilan inhibits neurogenic vasodilation and edema formation in the mouse skin.
    Banki E; Hajna Z; Kemeny A; Botz B; Nagy P; Bolcskei K; Toth G; Reglodi D; Helyes Z
    Neuropharmacology; 2014 Oct; 85():538-47. PubMed ID: 24973707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulatory effect of pituitary adenylate cyclase-activating polypeptide 6-38, M65 and vasoactive intestinal polypeptide 6-28 on trigeminal sensory neurons.
    Sághy É; Payrits M; Helyes Z; Reglődi D; Bánki E; Tóth G; Couvineau A; Szőke É
    Neuroscience; 2015 Nov; 308():144-56. PubMed ID: 26321242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary gland homogenates of Lutzomyia longipalpis and its vasodilatory peptide maxadilan cause plasma leakage via PAC1 receptor activation.
    Svensjö E; Saraiva EM; Bozza MT; Oliveira SM; Lerner EA; Scharfstein J
    J Vasc Res; 2009; 46(5):435-46. PubMed ID: 19176972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Backup Mechanisms Maintain PACAP/VIP-Induced Arterial Relaxations in Pituitary Adenylate Cyclase-Activating Polypeptide-Deficient Mice.
    Ivic I; Fulop BD; Juhasz T; Reglodi D; Toth G; Hashimoto H; Tamas A; Koller A
    J Vasc Res; 2017; 54(3):180-192. PubMed ID: 28490016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAC₁ receptors mediate positive chronotropic responses to PACAP-27 and VIP in isolated mouse atria.
    Hoover DB; Girard BM; Hoover JL; Parsons RL
    Eur J Pharmacol; 2013 Aug; 713(1-3):25-30. PubMed ID: 23665113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maxadilan, the Lutzomyia longipalpis vasodilator, drives plasma leakage via PAC1-CXCR1/2-pathway.
    Svensjö E; Saraiva EM; Amendola RS; Barja-Fidalgo C; Bozza MT; Lerner EA; Teixeira MM; Scharfstein J
    Microvasc Res; 2012 Mar; 83(2):185-93. PubMed ID: 22036674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pituitary adenylate cyclase activating polypeptide-38 on sensory neuropeptide release and neurogenic inflammation in rats and mice.
    Németh J; Reglödi D; Pozsgai G; Szabó A; Elekes K; Pintér E; Szolcsányi J; Helyes Z
    Neuroscience; 2006 Nov; 143(1):223-30. PubMed ID: 16938409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
    Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
    Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous inhibition of hippocampal LTD and depotentiation by vasoactive intestinal peptide VPAC1 receptors.
    Cunha-Reis D; Aidil-Carvalho Mde F; Ribeiro JA
    Hippocampus; 2014 Nov; 24(11):1353-63. PubMed ID: 24935659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
    Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAC1 receptors mediate pituitary adenylate cyclase-activating polypeptide- and progesterone-facilitated receptivity in female rats.
    Apostolakis EM; Riherd DN; O'Malley BW
    Mol Endocrinol; 2005 Nov; 19(11):2798-811. PubMed ID: 15976009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the involvement of VPAC1 and VPAC2 receptors in pressure-induced vasodilatation in rodents.
    Fizanne L; Sigaudo-Roussel D; Saumet JL; Fromy B
    J Physiol; 2004 Jan; 554(Pt 2):519-28. PubMed ID: 14578481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A structure-function study of PACAP using conformationally restricted analogs: Identification of PAC1 receptor-selective PACAP agonists.
    Ramos-Álvarez I; Mantey SA; Nakamura T; Nuche-Berenguer B; Moreno P; Moody TW; Maderdrut JL; Coy DH; Jensen RT
    Peptides; 2015 Apr; 66():26-42. PubMed ID: 25698233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VPAC1 and VPAC2 receptors mediate tactile hindpaw hypersensitivity and carotid artery dilatation induced by PACAP38 in a migraine relevant mouse model.
    Guo S; Rasmussen RH; Hay-Schmidt A; Ashina M; Asuni AA; Jensen JM; Holm A; Lauritzen SP; Dorsam G; Hannibal J; Georg B; Kristensen DM; Olesen J; Christensen SL
    J Headache Pain; 2024 Jul; 25(1):126. PubMed ID: 39085771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VIP and PACAP effects on mouse major pelvic ganglia neurons.
    Tompkins JD; Girard BM; Vizzard MA; Parsons RL
    J Mol Neurosci; 2010 Nov; 42(3):390-6. PubMed ID: 20428965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential activation of guinea pig intrinsic cardiac neurons by the PAC1 agonists maxadilan and pituitary adenylate cyclase-activating polypeptide 27 (PACAP27).
    Hoover DB; Tompkins JD; Parsons RL
    J Pharmacol Exp Ther; 2009 Oct; 331(1):197-203. PubMed ID: 19602551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal astrocytic activation contributes to both induction and maintenance of pituitary adenylate cyclase-activating polypeptide type 1 receptor-induced long-lasting mechanical allodynia in mice.
    Yokai M; Kurihara T; Miyata A
    Mol Pain; 2016; 12():. PubMed ID: 27175011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.